We are live on ! Find out more
MSL

Mackay Shields LLC Portfolio holdings

AUM $2.73B
1-Year Est. Return 2.13%
This Fund
S&P 500
This Quarter Est. Return
+0.7%
1 Year Est. Return
+2.13%
3 Year Est. Return
+7.81%
5 Year Est. Return
+19%
10 Year Est. Return
+113.23%
AUM
$10.6B
AUM Growth
-$29M
Cap. Flow
-$2.95B
Cap. Flow %
-27.83%
Top 10 Hldgs %
25.65%
Holding
722
New
10
Increased
39
Reduced
477
Closed
11

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$19.8M
2
TSM icon
TSMC
TSM
+$10.7M
3
MTCH icon
Match Group
MTCH
+$6.4M
4
VST icon
Vistra
VST
+$5.66M
5
CPLB
NYLI MacKay Core Plus Bond ETF
CPLB
+$4.99M

Sector Composition

Rank Sector Weight
1 Technology 13.42%
2 Financials 7.36%
3 Healthcare 6.77%
4 Consumer Discretionary 6.29%
5 Communication Services 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWF
526
AllianceBernstein Global High Income Fund
AWF
$867M
$828K 0.01%
67,463
EIM
527
Eaton Vance Municipal Bond Fund
EIM
$492M
$806K 0.01%
60,261
-192,440
-76% -$2.65M
RL icon
528
Ralph Lauren
RL
$22.2B
$803K 0.01%
7,234
-212
-3% -$24.5K
HYT icon
529
BlackRock Corporate High Yield Fund
HYT
$1.36B
$772K 0.01%
63,317
GAP
530
The Gap Inc
GAP
$6.84B
$708K 0.01%
31,192
-919
-3% -$25.4K
WBD icon
531
Warner Bros
WBD
$64.6B
$643K 0.01%
25,328
-747
-3% -$21K
UAA icon
532
Under Armour
UAA
$3B
$571K 0.01%
28,281
-834
-3% -$18.4K
UA icon
533
Under Armour Class C
UA
$2.92B
$511K ﹤0.01%
29,219
-861
-3% -$16.5K
QYLD icon
534
Global X NASDAQ-100 Covered Call ETF
QYLD
$7.97B
$451K ﹤0.01%
20,422
LQD icon
535
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$439K ﹤0.01%
3,300
-682
-17% -$92.2K
ARDC
536
Are Dynamic Credit Allocation Fund
ARDC
$297M
$437K ﹤0.01%
27,018
NWS icon
537
News Corp Class B
NWS
$16.4B
$425K ﹤0.01%
18,258
-538
-3% -$12.3K
NBO
538
DELISTED
Neuberger Berman New York Municipal Fund Inc.
NBO
$338K ﹤0.01%
25,745
BYM
539
DELISTED
BlackRock Municipal Income Quality Trust
BYM
$335K ﹤0.01%
21,958
-1,347
-6% -$21.5K
TPB icon
540
Turning Point Brands
TPB
$1.47B
$325K ﹤0.01%
6,802
ACWI icon
541
iShares MSCI ACWI ETF
ACWI
$32.6B
$315K ﹤0.01%
3,154
-11,846
-79% -$1.22M
MBB icon
542
iShares MBS ETF
MBB
$39B
$296K ﹤0.01%
+2,737
New +$297K
MELI icon
543
Mercado Libre
MELI
$91.3B
$274K ﹤0.01%
163
-37
-19% -$64.1K
JD icon
544
JD.com
JD
$40.8B
$267K ﹤0.01%
3,699
+499
+16% +$36.8K
XYZ
545
Block Inc
XYZ
$45.9B
$240K ﹤0.01%
1,000
BIDU icon
546
Baidu
BIDU
$35.8B
$222K ﹤0.01%
1,447
+347
+32% +$57K
BX icon
547
Blackstone
BX
$104B
$221K ﹤0.01%
+1,900
New +$220K
JILL icon
548
J. Jill
JILL
$252M
$217K ﹤0.01%
12,465
ELS icon
549
Equity Lifestyle Properties
ELS
$12.8B
$204K ﹤0.01%
+2,606
New +$214K
BRW
550
Saba Capital Income & Opportunities Fund
BRW
$338M
$132K ﹤0.01%
14,489
-13,608
-48% -$125K

Similar funds

Mackay Shields LLC's Q3 2021 Portfolio in Review

As of Q3 2021, Mackay Shields LLC held 722 positions worth $10.6B, down 0.27% from $10.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Mackay Shields LLC withdrew a net $2.95B in Q3 2021, closing 11 positions and reducing 477 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $6.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Mackay Shields LLC opened a new position in Moderna worth $20.7M.

  • Mackay Shields LLC's largest Q3 2021 buy was Moderna: 53,663 shares worth $20.7M.
  • Mackay Shields LLC added most to TSMC in Q3 2021, an estimated $10.7M increase.
  • Mackay Shields LLC's biggest Q3 2021 reduction was Lam Research, cutting an estimated $36.4M.
  • Mackay Shields LLC fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $6.41M.
  • Mackay Shields LLC's ten largest holdings make up 26% of its $10.6B portfolio in Q3 2021.
  • Mackay Shields LLC opened 10 new positions and closed 11 in Q3 2021.
  • Mackay Shields LLC's portfolio value fell 0.27% quarter-over-quarter to $10.6B.

Based on Mackay Shields LLC's 13F filing for Q3 2021, filed 12 Nov 2021.